Literature DB >> 19482474

Outcome measures in Duchenne muscular dystrophy: are we ready for the new therapeutic era?

Ingemar S J Merkies1, Catharina G Faber.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19482474     DOI： 10.1016/j.nmd.2009.04.005

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN： 0960-8966            Impact factor:   4.296


× No keyword cloud information.
  3 in total

1.  In vivo canine muscle function assay.

Authors:  Martin K Childers; Robert W Grange; Joe N Kornegay
Journal:  J Vis Exp       Date:  2011-04-05       Impact factor: 1.355

2.  A functional scale for spinal and bulbar muscular atrophy: Cross-sectional and longitudinal study.

Authors:  Atsushi Hashizume; Masahisa Katsuno; Keisuke Suzuki; Haruhiko Banno; Noriaki Suga; Tomoo Mano; Amane Araki; Yasuhiro Hijikata; Christopher Grunseich; Angela Kokkinis; Akihiro Hirakawa; Hirohisa Watanabe; Masahiko Yamamoto; Kenneth H Fischbeck; Gen Sobue
Journal:  Neuromuscul Disord       Date:  2015-03-20       Impact factor: 4.296

3.  Reevaluating measures of disease progression in facioscapulohumeral muscular dystrophy.

Authors:  Jeffrey M Statland; Michael P McDermott; Chad Heatwole; William B Martens; Shree Pandya; E L van der Kooi; John T Kissel; Kathryn R Wagner; Rabi Tawil
Journal:  Neuromuscul Disord       Date:  2013-02-11       Impact factor: 4.296
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.